Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines

1990 ◽  
Vol 42 (3) ◽  
pp. 135-142 ◽  
Author(s):  
Mitsuo Oshimura ◽  
Hiroyuki Kugoh ◽  
Minoru Koi ◽  
Motoyuki Shimizu ◽  
Hideto Yamada ◽  
...  
1981 ◽  
Vol 28 (2) ◽  
pp. 119-124 ◽  
Author(s):  
S. Korec ◽  
R. B. Herberman ◽  
G. B. Cannon ◽  
J. Reid ◽  
J. A. Braatz

2004 ◽  
Vol 203 (2) ◽  
pp. 145-154 ◽  
Author(s):  
Dharam P. Chopra ◽  
Raymond E. Menard ◽  
Jakub Januszewski ◽  
Raymond R. Mattingly

1992 ◽  
Vol 88 (5) ◽  
pp. 524-528 ◽  
Author(s):  
R. Parshad ◽  
F. M. Price ◽  
M. Oshimura ◽  
J. C. Barrett ◽  
H. Satoh ◽  
...  

Science ◽  
1987 ◽  
Vol 236 (4798) ◽  
pp. 175-180 ◽  
Author(s):  
B. Weissman ◽  
P. Saxon ◽  
Pasquale ◽  
G. Jones ◽  
A. Geiser ◽  
...  

1989 ◽  
Vol 2 (1) ◽  
pp. 12-21 ◽  
Author(s):  
Minoru Koi ◽  
Hiroyuki Morita ◽  
Hideto Yamada ◽  
Hitoshi Satoh ◽  
J. Carl Barrett ◽  
...  

Endocrine ◽  
2015 ◽  
Vol 54 (1) ◽  
pp. 123-128 ◽  
Author(s):  
Francesca Coperchini ◽  
Patrizia Pignatti ◽  
Paola Leporati ◽  
Andrea Carbone ◽  
Laura Croce ◽  
...  

1983 ◽  
Vol 50 (03) ◽  
pp. 726-730 ◽  
Author(s):  
Hamid Al-Mondhiry ◽  
Virginia McGarvey ◽  
Kim Leitzel

SummaryThis paper reports studies on the interaction between human platelets, the plasma coagulation system, and two human tumor cell lines grown in tissue culture: Melanoma and breast adenocarcinoma. The interaction was monitored through the use of 125I- labelled fibrinogen, which measures both thrombin activity generated by cell-plasma interaction and fibrin/fibrinogen binding to platelets and tumor cells. Each tumor cell line activates both the platelets and the coagulation system simultaneously resulting in the generation of thrombin or thrombin-like activity. The melanoma cells activate the coagulation system through “the extrinsic pathway” with a tissue factor-like effect on factor VII, but the breast tumor seems to activate factor X directly. Both tumor cell lines activate platelets to “make available” a platelet- derived procoagulant material necessary for the conversion of prothrombin to thrombin. The tumor-derived procoagulant activity and the platelet aggregating potential of cells do not seem to be inter-related, and they are not specific to malignant cells.


Sign in / Sign up

Export Citation Format

Share Document